Enhancement of cell mediated immune responses using lipid depleted lentivirus as immunogen: A novel approach for inducing recognition of new viral epitopes

Moiz Kitabwalla, Francois Villinger, Hassibullah Akeefe, Zhaohao Liao, Ann E. Mayne, Lisa Gargano, Adam P. Conner, Jo Ann Maltais, Gretchen Kunas, James Hildreth, Aftab A. Ansari, Marc Bellotti

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We tested the hypothesis that removal of viral lipids using diisopropylether can enhance antigenicity of SIVmac251. DIPE delipidation removed cholesterol from SIVmac251 without significant loss of viral protein or RNA. Mice immunized with the same SIV preparation but boosted with delipidated SIVmac251 exhibited significantly broader and higher cellular and humoral immune responses compared to live or AT-2-inactivated virus. As little as 1 μg (total protein) of delipidated virus was sufficient to induce such enhanced immune responses. Thus, solvent treated lentivirus may provide a novel strategy to generate immune responses to additional viral epitopes.

Original languageEnglish (US)
Pages (from-to)4666-4677
Number of pages12
JournalVaccine
Volume23
Issue number38
DOIs
StatePublished - Sep 7 2005
Externally publishedYes

Fingerprint

Lentivirus
cell-mediated immunity
epitopes
Epitopes
immune response
Viruses
antigens
Lipids
viruses
viral proteins
Viral RNA
Viral Proteins
Humoral Immunity
lipids
humoral immunity
Cellular Immunity
Cholesterol
cholesterol
RNA
mice

Keywords

  • Delipidation
  • SIV
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Enhancement of cell mediated immune responses using lipid depleted lentivirus as immunogen : A novel approach for inducing recognition of new viral epitopes. / Kitabwalla, Moiz; Villinger, Francois; Akeefe, Hassibullah; Liao, Zhaohao; Mayne, Ann E.; Gargano, Lisa; Conner, Adam P.; Maltais, Jo Ann; Kunas, Gretchen; Hildreth, James; Ansari, Aftab A.; Bellotti, Marc.

In: Vaccine, Vol. 23, No. 38, 07.09.2005, p. 4666-4677.

Research output: Contribution to journalArticle

Kitabwalla, M, Villinger, F, Akeefe, H, Liao, Z, Mayne, AE, Gargano, L, Conner, AP, Maltais, JA, Kunas, G, Hildreth, J, Ansari, AA & Bellotti, M 2005, 'Enhancement of cell mediated immune responses using lipid depleted lentivirus as immunogen: A novel approach for inducing recognition of new viral epitopes', Vaccine, vol. 23, no. 38, pp. 4666-4677. https://doi.org/10.1016/j.vaccine.2005.04.038
Kitabwalla, Moiz ; Villinger, Francois ; Akeefe, Hassibullah ; Liao, Zhaohao ; Mayne, Ann E. ; Gargano, Lisa ; Conner, Adam P. ; Maltais, Jo Ann ; Kunas, Gretchen ; Hildreth, James ; Ansari, Aftab A. ; Bellotti, Marc. / Enhancement of cell mediated immune responses using lipid depleted lentivirus as immunogen : A novel approach for inducing recognition of new viral epitopes. In: Vaccine. 2005 ; Vol. 23, No. 38. pp. 4666-4677.
@article{cf2a0bc465e24a5eb2398ae06e7fd288,
title = "Enhancement of cell mediated immune responses using lipid depleted lentivirus as immunogen: A novel approach for inducing recognition of new viral epitopes",
abstract = "We tested the hypothesis that removal of viral lipids using diisopropylether can enhance antigenicity of SIVmac251. DIPE delipidation removed cholesterol from SIVmac251 without significant loss of viral protein or RNA. Mice immunized with the same SIV preparation but boosted with delipidated SIVmac251 exhibited significantly broader and higher cellular and humoral immune responses compared to live or AT-2-inactivated virus. As little as 1 μg (total protein) of delipidated virus was sufficient to induce such enhanced immune responses. Thus, solvent treated lentivirus may provide a novel strategy to generate immune responses to additional viral epitopes.",
keywords = "Delipidation, SIV, Vaccine",
author = "Moiz Kitabwalla and Francois Villinger and Hassibullah Akeefe and Zhaohao Liao and Mayne, {Ann E.} and Lisa Gargano and Conner, {Adam P.} and Maltais, {Jo Ann} and Gretchen Kunas and James Hildreth and Ansari, {Aftab A.} and Marc Bellotti",
year = "2005",
month = "9",
day = "7",
doi = "10.1016/j.vaccine.2005.04.038",
language = "English (US)",
volume = "23",
pages = "4666--4677",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "38",

}

TY - JOUR

T1 - Enhancement of cell mediated immune responses using lipid depleted lentivirus as immunogen

T2 - A novel approach for inducing recognition of new viral epitopes

AU - Kitabwalla, Moiz

AU - Villinger, Francois

AU - Akeefe, Hassibullah

AU - Liao, Zhaohao

AU - Mayne, Ann E.

AU - Gargano, Lisa

AU - Conner, Adam P.

AU - Maltais, Jo Ann

AU - Kunas, Gretchen

AU - Hildreth, James

AU - Ansari, Aftab A.

AU - Bellotti, Marc

PY - 2005/9/7

Y1 - 2005/9/7

N2 - We tested the hypothesis that removal of viral lipids using diisopropylether can enhance antigenicity of SIVmac251. DIPE delipidation removed cholesterol from SIVmac251 without significant loss of viral protein or RNA. Mice immunized with the same SIV preparation but boosted with delipidated SIVmac251 exhibited significantly broader and higher cellular and humoral immune responses compared to live or AT-2-inactivated virus. As little as 1 μg (total protein) of delipidated virus was sufficient to induce such enhanced immune responses. Thus, solvent treated lentivirus may provide a novel strategy to generate immune responses to additional viral epitopes.

AB - We tested the hypothesis that removal of viral lipids using diisopropylether can enhance antigenicity of SIVmac251. DIPE delipidation removed cholesterol from SIVmac251 without significant loss of viral protein or RNA. Mice immunized with the same SIV preparation but boosted with delipidated SIVmac251 exhibited significantly broader and higher cellular and humoral immune responses compared to live or AT-2-inactivated virus. As little as 1 μg (total protein) of delipidated virus was sufficient to induce such enhanced immune responses. Thus, solvent treated lentivirus may provide a novel strategy to generate immune responses to additional viral epitopes.

KW - Delipidation

KW - SIV

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=22144481669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144481669&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.04.038

DO - 10.1016/j.vaccine.2005.04.038

M3 - Article

C2 - 15955600

AN - SCOPUS:22144481669

VL - 23

SP - 4666

EP - 4677

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 38

ER -